Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
NeuroStar revenue
NeuroStar's revenue is $74.9 million.
What is NeuroStar's revenue?
- NeuroStar's revenue growth from 2017 to 2024 is 85.22%.
- NeuroStar has 150 employees, and the revenue per employee ratio is $499,266.
- NeuroStar's peak quarterly revenue was $22.5M in 2024(q4).
- NeuroStar peak revenue was $74.9M in 2024.
- NeuroStar annual revenue for 2023 was 71.3M, 9.42% growth from 2022.
- NeuroStar annual revenue for 2024 was 74.9M, 4.96% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
NeuroStar historical revenue
NeuroStar's peak revenue was $74.9M in 2024. The peak quarterly revenue was $22.5M in 2024(q4).
NeuroStar's revenue increased from $40.4m in 2017 to $74.9M currently. That's a 85.22% change in annual revenue.
NeuroStar annual revenue
NeuroStar annual revenue over time
| Fiscal year / year | NeuroStar revenue |
|---|---|
| 2017 | $40.4M |
| 2018 | $52.8M |
| 2019 | $62.7M |
| 2020 | $49.2M |
| 2021 | $55.3M |
| 2022 | $65.2M |
| 2023 | $71.3M |
| 2024 | $74.9M |
How accurately did NeuroStar's revenue projections match actual performance?
NeuroStar annual growth
NeuroStar saw the greatest revenue growth in 2018, when revenue increased by 30.53%.
NeuroStar had the lowest revenue growth in 2020, when revenue changed by -21.41%.
NeuroStar annual growth rate over time
| Year | NeuroStar growth |
|---|---|
| 2018 | 31%↑ |
| 2019 | 19%↑ |
| 2020 | -21%↓ |
| 2021 | 12%↑ |
| 2022 | 18%↑ |
| 2023 | 9%↑ |
| 2024 | 5%↑ |
NeuroStar quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
NeuroStar quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | $13.3M | $13.7M | $15.6M |
| 2019 | $12.7M | $16.6M | $16.0M | $17.4M |
| 2020 | $11.5M | $9.7M | $12.4M | $15.6M |
| 2021 | $12.3M | $14.2M | $13.8M | $15.0M |
| 2022 | $14.2M | $16.3M | $16.5M | $18.2M |
| 2023 | $15.5M | $17.6M | $17.9M | $20.3M |
| 2024 | $17.4M | $16.5M | $18.5M | $22.5M |
NeuroStar jobs nearby
Do you work at NeuroStar?
Is NeuroStar transparent about its revenue structure?
NeuroStar financing
NeuroStar received early financing of $15.0M on 2003-04-15.
| Series | Round size | Date |
|---|---|---|
| Series A | $15M | 04/2003 |
| Series B | $8.5M | 03/2005 |
| Series C | $35M | 08/2006 |
| Series D | $30M | 10/2009 |
| Series E | $30M | 05/2011 |
| Series F | $34.3M | 04/2015 |
| Series G | $15M | 06/2017 |
| Debt Financing | $50M | 01/2020 |
| Post Ipo Equity | $80.6M | 02/2021 |
NeuroStar investors
| Investors | Security type |
|---|---|
| ONSET Ventures | Series A |
| InterWest Partners | Series A |
| Investor Growth Capital Limited | Series A |
| KBL Healthcare Ventures | Series A |
| ONSET Ventures | Series B |
| InterWest Partners | Series B |
| Accuitive Medical Ventures | Series B |
| Investor Growth Capital Limited | Series B |
| Three Arch Partners | Series B |
| ONSET Ventures | Series C |
| InterWest Partners | Series C |
| Three Arch Partners | Series C |
| Investor Growth Capital Limited | Series C |
| KBL Healthcare Ventures | Series C |
| Quaker Partners | Series C |
| ONSET Ventures | Series D |
| Partisan Management Group | Series D |
| InterWest Partners | Series D |
| Three Arch Partners | Series D |
| Investor Growth Capital Limited | Series D |
| Quaker BioVentures | Series D |
| KBL Healthcare Ventures | Series D |
| New Leaf Venture Partners | Series D |
| Polaris Partners | Series E |
| ONSET Ventures | Series E |
| InterWest Partners | Series E |
| Pfizer Venture Investments | Series E |
| Investor Growth Capital Limited | Series E |
| Quaker BioVentures | Series E |
| Three Arch Partners | Series E |
| New Leaf Venture Partners | Series E |
| Polaris Partners | Series F |
| ONSET Ventures | Series F |
| Partisan Management Group | Series F |
| Pfizer Venture Investments | Series F |
| GE Ventures | Series F |
| Three Arch Partners | Series F |
| Quaker BioVentures | Series F |
| Investor Growth Capital Limited | Series F |
| New Leaf Venture Partners | Series F |
| Ascension Ventures | Series G |
| Polaris Partners | Series G |
| Industry Ventures | Series G |
| ONSET Ventures | Series G |
| InterWest Partners | Series G |
| Pfizer Venture Investments | Series G |
| GE Ventures | Series G |
| Accuitive Medical Ventures | Series G |
| Investor Growth Capital Limited | Series G |
| Three Arch Partners | Series G |
| KBL Healthcare Ventures | Series G |
| New Leaf Venture Partners | Series G |
NeuroStar competitors
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Stryker | $69,470 | $22.6B | 43,000 | 2,076 |
| Abiomed | $99,022 | $1.0B | 1,536 | - |
| Invuity | $63,343 | $39.6M | 161 | - |
| Bioventus | $54,381 | $321.2M | 1,062 | 51 |
| Axogen | $71,099 | $187.3M | 297 | 33 |
| Aastrom Biosciences | $51,812 | - | - | - |
| TUV Rhienland OpenSky Inc. | $63,609 | $17.0M | 375 | 23 |
| At Comm | $63,141 | $16.0M | 171 | - |
| InterSystems | $80,720 | $644.0M | 1,780 | 26 |
| Applied Discovery | $73,893 | $510,000 | 7 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of NeuroStar, including salaries, political affiliations, employee data, and more, in order to inform job seekers about NeuroStar. The employee data is based on information from people who have self-reported their past or current employments at NeuroStar. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by NeuroStar. The data presented on this page does not represent the view of NeuroStar and its employees or that of Zippia.
NeuroStar may also be known as or be related to NEURONETICS, INC., NeuroStar, Neuronetics and Neuronetics, Inc.